InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,995.54
(
0.38%
)
US TECH 100
20,565.20
(
0.11%
)
Dow Jones
43,988.99
(
0.59%
)
Brent Oil
73.89
(
0.00%
)
Bitcoin
76,355.69
(
-0.28%
)
Post# of 141
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Patricia_1

Send PM Follow Ignore
Followers 4
Posts 579
Boards Moderated 0
Alias Born 04/14/2001

Patricia_1

Member Level

Re: Patricia_1 post# 9

Wednesday, 11/26/2003 9:44:05 AM

Wednesday, November 26, 2003 9:44:05 AM

Post# of 141
Dr. Parkinsons' words in news article 10/30/03

XenoTech Founder and CEO, Dr. Andrew Parkinson, states, "Our characterization studies corroborate and extend the earlier findings of MultiCell and Pfizer scientists presented at the 2002 ISSX meeting. Our results show that MCT's immortalized hepatocytes retain several functional drug metabolizing enzymes that previously had not been studied." Dr. Parkinson adds, "MCT's cell lines represent a breakthrough technology that has the potential to revolutionize how the pharmaceutical industry screens new drug entities, we anticipate significant worldwide interest in MCT's cell lines."



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up